Skip to main content
Professional Technical IVT

aprotinin

Pronunciation: ap-ROH-tin-in

A serine protease inhibitor used to reduce bleeding during cardiac surgery by inhibiting fibrinolysis.

Full Definition

Aprotinin is a natural protease inhibitor derived from bovine lungs that was historically used in cardiac surgery to reduce perioperative bleeding. It works by inhibiting plasmin, kallikrein, and other serine proteases involved in coagulation and fibrinolysis. The drug was withdrawn from many markets in 2007 due to safety concerns regarding increased mortality and renal dysfunction, though it has been reintroduced in some regions under restricted use. In cardiothoracic anesthesia contexts, editors should be aware of its controversial history and current limited availability.

Usage

Usage note: Historical context regarding withdrawal and reintroduction should be noted when editing contemporary materials.

In Context

  • "Aprotinin administration was associated with reduced transfusion requirements in high-risk cardiac procedures." — research paper
  • "The use of aprotinin remains restricted due to previous safety concerns." — clinical protocol

Also known as

Trasylol

Don't confuse with

apropos aprepitant

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON